海外の治験の状況「1」での検索結果
11979件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Study of TAC-101 as Second Line Treatment in Patients With Advanced Hepatocellular Carcinoma Who Received Sorafenib as First Line Therapy
- Hepatocellular Carcinoma
- Italy
- 2008-05-28
Not Recruiting
- Study of the efficacy and safety of BOTOX® in the treatment of facial wrinkles (crow's feet lines and frown lines)
- Treatment of lateral canthal rhytides in the periorbital region (CFL) MedDRA version: 13.1 Level: PT Classification code 10040954 Term: Skin wrinkling System Organ Class: 10040785 - Skin and subcutaneous tissue disorders ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Canada, Germany, United States
- 2010-08-03
Not Recruiting
- A multicentre phase II trial to determine the efficacy of RAD 001 (everolimus, Afinitor®) as second line therapy in patients with transitional cell carcinoma (TCC) of the urothelium which failed or progressed after first line chemotherapy. - AFINIVEST
- Patients who have metastatic or locally advanced inoperable transitional cell carcinoma of the urothelium who failed prior systemic chemotherapy
- France
- 2010-06-18
Not Recruiting
- Early phase triple blind placebo controlled RCT of simvastatin treatment for autism in young children with Neurofibromatosis Type 1
- Neurofibromatosis Type 1 br>MedDRA version: 14.1 Level: LLT Classification code 10029270 Term: Neurofibromatosis, type 1 (von Recklinghausen's disease) System Organ Class: 100000004850 ;Therapeutic area: Body processes [G] - Genetic Phenomena [G05]
- United Kingdom
- 2013-04-05
Recruiting
- Second-line Therapy With Nal-IRI After Failure Gemcitabine/Nab-paclitaxel in Advanced Pancreatic Cancer - Predictive Role of 1st-line Therapy
- Locally Advanced Pancreatic Cancer;Metastatic Pancreatic Cancer
- Germany
- 2018-01-19
Not Recruiting
- Efficacy and safety of adding LX4211 (an investigational oral compound) for patients with Type 1 Diabetes Mellitus (T1D) who have inadequate control of their blood glucose (sugar) levels on insulin alone.
- Type 1 Diabetes Mellitus br>MedDRA version: 17.1 Level: PT Classification code 10067584 Term: Type 1 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Austria, Belgium, Bulgaria, France, Germany, Hungary, Israel, Italy, Lithuania, Netherlands, Poland, Romania, Slovakia, Spain, Sweden, Switzerland, United Kingdom
- 2015-03-05
Authorised
- A Study to Investigate Dance 501 (Human Insulin Inhalation Solution and Inhaler) in Subjects with Type 1 Diabetes Mellitus (T1DM)
- Type 1 Diabetes Mellitus br>MedDRA version: 20.0 Level: PT Classification code 10067584 Term: Type 1 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Germany
- 2018-09-25
Recruiting
- Registry of Congenital Dyserythropoietic Anemia
- Congenital Dyserythropoietic Anemia
- France
- 2019-06-05
Recruiting
- MT10109L in the Long-term, Open-label Treatment of Glabellar Lines and Lateral Canthal Lines
- Glabellar Lines;Lateral Canthal Lines
- Belgium, Canada, Germany, Russian Federation, United Kingdom, United States
- 2019-10-23
Not Recruiting
- Transcranial Alternating Current Stimulation (tACS) in Adult Classic Galactosemia
- Classic Galactosemia
- The Netherlands
- 2019-12-17
Not recruiting
- Orchestra Pregnancy Observational Study in Poland
- Type 1 Diabetes Mellitus;Pregnancy;Type 1 Diabetes Mellitus;Pregnancy;Type 1 Diabetes Mellitus;Pregnancy
- Poland
- 2013-01-28
Not recruiting
- Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes
- Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus
- Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Hungary, Israel, Italy, Mexico, Romania, Spain, Sweden, United Kingdom, United States
- 2014-10-15
Not Recruiting
- A PHASE III CLINICAL TRIAL TO STUDY THE SAFETY AND EFFICACY OF MK-1293 COMPARED TO LANTUS™ IN SUBJECTS WITH TYPE 1 DIABETES MELLITUS
- -E10 Insulin-dependent diabetes mellitus br>Insulin-dependent diabetes mellitus;Insulin-dependent diabetes mellitus
- Australia, Colombia, Mexico, New Zealand, South Africa, Spain, United States
- 2014-02-27
Not recruiting
- An Open Label, Pilot Investigation, to Assess the Safety and Efficacy of Transplantation of Macro-encapsulated Human Islets Within the Bioartificial Pancreas Beta-Air in Patients With Type 1 Diabetes Mellitus
- Long-standing Type 1 Diabetes Mellitus;Long-standing Type 1 Diabetes Mellitus;Long-standing Type 1 Diabetes Mellitus
- Sweden
- 2014-02-13
Not recruiting
- Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes
- Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus
- Argentina, Belarus, Belgium, Canada, Chile, Germany, Japan, Netherlands, Poland, Russian Federation, Sweden, Switzerland, United Kingdom, United States
- 2015-06-01
Recruiting
- Insulin Pump vs Multiple Daily Injections of Insulin and Glyco-metabolic Control in Type 1 Diabetic Patients
- Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus
- Italy
- 2018-02-19
Recruiting
- Pancreatic Islet Transplantation in the Anterior Chamber of the Human Eye - a Pilot Study
- Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus
- Switzerland
- 2016-03-31
Not recruiting
- Safety and Efficacy Study of Encapsulated Human Islets Allotransplantation to Treat Type 1 Diabetes
- Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus
- Belgium
- 2008-11-12
Not Recruiting
- Assessment of the Effect of Tegaserod (2 mg Tid and 6 mg Tid) on Dyspeptic Symptoms in Diabetic Patients With Symptoms of Diabetic Gastropathy
- -E104 Insulin-dependent diabetes mellitus, with neurological complications Insulin-dependent diabetes mellitus, with neurological complications;Insulin-dependent diabetes mellitus, with neurological complications
- Peru, Switzerland
- 2004-04-05
Not Recruiting
- Taxotere-Mono Studie: 1st-Line Docetaxel versus Gemcitabin Monotherapie mit festgelegter platinhaltiger 2nd-Line bei PD bei Patienten mit metastasiertem nicht-kleinzelligem Bronchial-Karzinom; eine randomisierte, Phase II Studie English translation: Clinical trial Taxotere Monotherapy: 1st-line Docetaxel versus Gemcitabine monotherapy with defined 2nd-line containing platinum when PD occurs, in patients with metastatic non small cell lung cancer; a randomized, phase II trial - 1st line Docetaxel vs. Gemcitabin (Monotherapie)
- Treatment of metastatic non small cell lung cancer (NSCLC) MedDRA version: 8.1 Level: LLT Classification code 10029514 Term: Non-small cell lung cancer NOS
- Germany
- 2006-09-26